Send the following on WhatsApp
Continue to ChatI liked this article on M3 India: A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequately controlled by glimepiride and metformin. Have a read: https://www.m3india.in/contents/journal/a-randomized-placebo-controlled-clinical-trial?utm_campaign=unset&utm_medium=share&utm_source=ref_wa